Sign in

CIK 0001743881

  • Large accelerated filer

BridgeBio Pharma, Inc.

Sign in to watch
Ticker
BBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 650-391-9740
Business address
3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
Former names
BridgeBio Pharma LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,676,804
in 3 filings, $1.7M under 10b5-1 plans

Net −$1,676,804. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-11-16 HENDERSON MICHAEL THOMAS Chief Business Officer Option exercise · Restricted Stock Units −12,813 179,375
2020-11-16 STEPHENSON BRIAN C See Remarks Option exercise +1,710 290,677
2020-11-16 STEPHENSON BRIAN C See Remarks Shares withheld for taxes −592 $44.33 $26K 290,085
2020-11-16 STEPHENSON BRIAN C See Remarks Option exercise · Restricted Stock Units −1,710 23,937
2020-11-16 Sinha Uma Chief Scientific Officer Option exercise +469 16,460
2020-11-16 Sinha Uma Chief Scientific Officer Option exercise · Restricted Stock Units −469 6,563
2020-11-16 Cook Jennifer E. Director Option exercise +3,576 3,576
2020-11-16 Cook Jennifer E. Director Option exercise · Restricted Stock Units −3,576 3,576
2020-11-13 MCCORMICK FRANK Chairman of Oncology Sale −31,632 $42.22 $1.3M 1,268,836
2020-11-13 MCCORMICK FRANK Chairman of Oncology Sale −58,299 $42.91 $2.5M 1,210,537
2020-11-13 MCCORMICK FRANK Chairman of Oncology Sale −10,069 $43.57 $439K 1,200,468
2020-11-05 Turtle Cameron See Remarks Option exercise +2,500 $17.00 $43K 15,068
2020-11-05 Turtle Cameron See Remarks Sale −2,500 $42.05 $105K 12,568
2020-11-05 Turtle Cameron See Remarks Option exercise · Stock Option (Right to Buy) −2,500 268,000
2020-11-02 HENDERSON MICHAEL THOMAS Chief Business Officer Option exercise +10,000 $1.05 $11K 277,751
2020-11-02 HENDERSON MICHAEL THOMAS Chief Business Officer Sale −9,500 $38.33 $364K 268,251
2020-11-02 HENDERSON MICHAEL THOMAS Chief Business Officer Sale −500 $38.92 $19K 267,751
2020-11-02 HENDERSON MICHAEL THOMAS Chief Business Officer Option exercise · Stock Option (Right to Buy) −10,000 28,282
2020-10-16 HOMCY CHARLES J Chairman of Pharmaceuticals Option exercise +10,256 $17.00 $174K 1,214,023
2020-10-16 HOMCY CHARLES J Chairman of Pharmaceuticals Sale −10,256 $41.00 $420K 1,203,767

Page 43 of 44 · 868 trades